MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3899/jrheum.121281

Медицинская библиотека · The Journal of rheumatology · 2013

Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.

De Sanctis Sara, Marcovecchio M Loredana, Gaspari Stefania, Del Torto Marianna, Mohn Angelika, Chiarelli Francesco, Breda Luciana

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To investigate the effect of 1-year treatment with the anti-tumor necrosis factor-α (TNF-α) drug etanercept on lipid profile and oxidative stress in children and adolescents with juvenile idiopathic arthritis (JIA).

METHODS

Thirty children with JIA (22 females; mean age 12.3 ± SD 5.7 yrs), all eligible for anti-TNF-α treatment, were assessed at baseline and after 6- and 12-month treatment with etanercept. Disease activity was determined using the Juvenile Arthritis Disease Activity Score (JADAS). Blood samples were drawn to measure the acute-phase reactants C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), lipids, and the proinflammatory cytokines TNF-α, interleukin-1β (IL-1β), IL-6 and interferon-γ. To measure the oxidative stress marker 8-iso-prostaglandin F2α, 24-h urine samples were collected.

RESULTS

Inflammatory indicators (CRP and ESR) and JADAS scores improved significantly after 1 year of etanercept treatment (all p < 0.001). Proinflammatory cytokines showed significant reduction during the study period (all p < 0.001). Similar reductions were detected in total cholesterol (p < 0.001), low-density lipoprotein cholesterol (p = 0.04), and triglycerides (p < 0.001), whereas no significant change was found in high-density lipoprotein cholesterol. No side effects were observed during the treatment period.

CONCLUSION

This study shows for the first time that anti-TNF-α therapy for JIA is associated not only with a beneficial effect on clinical disease activity and inflammatory indexes, but also with improved lipid profile and oxidative stress. These findings suggest that TNF-α blockers might reduce atherosclerotic risk in children with JIA.

Для цитирования: De Sanctis Sara, Marcovecchio M Loredana, Gaspari Stefania, Del Torto Marianna, Mohn Angelika, Chiarelli Francesco, Breda Luciana. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.. The Journal of rheumatology. 2013. DOI: 10.3899/jrheum.121281.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.